Bioequivalence Assessment of Two Different Tablet Formulations of Diltiazem After Single and Repeated Doses in Healthy Subjects

References

• Betriu A., Chaitman B. R., Bourassa M. G., Breves G., Scholl J. M., Bruneau P., Gagné P., Chabot M. Beneficial effect of intravenous diltiazem in the acute management of paroxymal supraventricular tachiarrhythmias. Circulation 1983; 67: 88–941. Betriu A., Chaitman B. R., Bourassa M. G., Breves G., Scholl J. M., Bruneau P., Gagné P., Chabot M. Beneficial effect of intravenous diltiazem in the acute management of paroxymal supraventricular tachiarrhythmias. Circulation 1983; 67: 88–94
   PubMed Web of Science ®Google Scholar
• Goldestein R. E., Boccuzzi S. J., Cruess D., Nattel S. Diltiazem increases late-onset congestive heart failure in postinjection patients with early reduction in ejection fraction. The Adverse Experience Committee and the Multicenter Diltiazem Postinjection Research Group. Circulation 1991; 83: 52–602. Goldestein R. E., Boccuzzi S. J., Cruess D., Nattel S. Diltiazem increases late-onset congestive heart failure in postinjection patients with early reduction in ejection fraction. The Adverse Experience Committee and the Multicenter Diltiazem Postinjection Research Group. Circulation 1991; 83: 52–60
   PubMedGoogle Scholar
• Gottlieb S. S., Kukin M. L., Medina N., Yushah M., Packer M. Comparative hemodynamic effects of procainamide, tocainamide and encainide in severe chronic heart failure. Circulation 1990; 81: 860–8643. Gottlieb S. S., Kukin M. L., Medina N., Yushah M., Packer M. Comparative hemodynamic effects of procainamide, tocainamide and encainide in severe chronic heart failure. Circulation 1990; 81: 860–864
   PubMed Web of Science ®Google Scholar
• Bhom M., Schwinger R. H. G., Erdmann E. Different cardiodepressant potency of various calcium antagonists in human myocardium. Am. J. Cardiol. 1990; 65: 1039–10414. Bhom M., Schwinger R. H. G., Erdmann E. Different cardiodepressant potency of various calcium antagonists in human myocardium. Am. J. Cardiol. 1990; 65: 1039–1041
   PubMed Web of Science ®Google Scholar
• Champlain J., Petrovich M., Lebeau R., Yacine A., Nadeau R., Spernad J. Chronic effects of diltiazem on the hemodynamic and sympathoadrenal tone in responsive and nonresponsive hypertensive patients at rest and during isometric exercise. J. Cardio. Pharmacol 1991; 18: S36–S405. Champlain J., Petrovich M., Lebeau R., Yacine A., Nadeau R., Spernad J. Chronic effects of diltiazem on the hemodynamic and sympathoadrenal tone in responsive and nonresponsive hypertensive patients at rest and during isometric exercise. J. Cardio. Pharmacol 1991; 18: S36–S40
   PubMed Web of Science ®Google Scholar
• Ochs H. R., Anda L., Eichelbaum M., Greenblatt D. J. Diltiazem, verapamil and quinidine in patients with chronic atrial fibrillation. J. Clin. Pharmacol. 1985; 25: 204–2096. Ochs H. R., Anda L., Eichelbaum M., Greenblatt D. J. Diltiazem, verapamil and quinidine in patients with chronic atrial fibrillation. J. Clin. Pharmacol. 1985; 25: 204–209
   PubMed Web of Science ®Google Scholar
• Dias V. C., Weir S. J., Ellenbogen K. A. Pharmacokinetics and pharmacodynamics of intravenous diltiazem in patients with atrial fibrillation or atrial flutter. Circulation 1992; 86: 1421–14287. Dias V. C., Weir S. J., Ellenbogen K. A. Pharmacokinetics and pharmacodynamics of intravenous diltiazem in patients with atrial fibrillation or atrial flutter. Circulation 1992; 86: 1421–1428
   PubMed Web of Science ®Google Scholar
• Buckley M. M. T., Grant S. M., Goa R. L., McTavish D., Sorkin E. M. Diltiazem. A reappaisal of its pharmacological properties and therapeutic use. Drugs 1990; 39: 575–8068. Buckley M. M. T., Grant S. M., Goa R. L., McTavish D., Sorkin E. M. Diltiazem. A reappaisal of its pharmacological properties and therapeutic use. Drugs 1990; 39: 575–806
   PubMedGoogle Scholar
• Chaffman M., Brogden R. N. Diltiazem – a review of its pharmacological properties and therapeutic efficacy. Drugs 1985; 29: 387–4549. Chaffman M., Brogden R. N. Diltiazem – a review of its pharmacological properties and therapeutic efficacy. Drugs 1985; 29: 387–454
   PubMed Web of Science ®Google Scholar
• Chavas das Neves H. I., Gomes Da Silva M. D. R., Rocha M. P. Bioequivalence assessment of diltiazem preparations by means of discriminant analysis of data from solid-phase extraction and liquid chromatography. J. Pharm. Biomed. Anal. 1991; 9: 941–94710. Chavas das Neves H. I., Gomes Da Silva M. D. R., Rocha M. P. Bioequivalence assessment of diltiazem preparations by means of discriminant analysis of data from solid-phase extraction and liquid chromatography. J. Pharm. Biomed. Anal. 1991; 9: 941–947
   PubMed Web of Science ®Google Scholar
• Christrup L. L., Bonde J., Rasmussen S. N., Sonnergaad J. M., Jensen B. H. Single dose and steady-state pharmacokinetics of diltiazem administered in two different tablet formulations. Pharmacol. Toxicol 1992; 71: 305–30711. Christrup L. L., Bonde J., Rasmussen S. N., Sonnergaad J. M., Jensen B. H. Single dose and steady-state pharmacokinetics of diltiazem administered in two different tablet formulations. Pharmacol. Toxicol 1992; 71: 305–307
   PubMedGoogle Scholar
• Martindale.29th edn. The Extra Pharmacopoeia, London 1990–199012. Martindale.29th edn. The Extra Pharmacopoeia, London 1990–1990
   Google Scholar
• Wiens R. E., Runser D. J., Lacz J. P., Dimmit D. C. Quantitation of diltiazem and desacetyldiltiazem in dog plasma by high-performance liquid chromatography. J. Pharm. Sci. 1984; 73: 688–69213. Wiens R. E., Runser D. J., Lacz J. P., Dimmit D. C. Quantitation of diltiazem and desacetyldiltiazem in dog plasma by high-performance liquid chromatography. J. Pharm. Sci. 1984; 73: 688–692
   PubMed Web of Science ®Google Scholar
• Goebel K. J., Kölle E. U. Highperformance liquid chromatographic determination of diltiazem and four of its metabolites in plasma. Application to pharmacokinetics. J. Chromatog. 1985; 345: 355–36314. Goebel K. J., Kölle E. U. Highperformance liquid chromatographic determination of diltiazem and four of its metabolites in plasma. Application to pharmacokinetics. J. Chromatog. 1985; 345: 355–363
   PubMed Web of Science ®Google Scholar
• Boulieu R., Bonnefous J. L., Ferry S. Solid-phase extraction of diltiazem and its metabolites' plasma prior to high-performance liquid chromatography. J. Chromatog. 1990; 528: 542–54615. Boulieu R., Bonnefous J. L., Ferry S. Solid-phase extraction of diltiazem and its metabolites' plasma prior to high-performance liquid chromatography. J. Chromatog. 1990; 528: 542–546
   PubMed Web of Science ®Google Scholar